Additionally, as seen in connection with the COVID-19 pandemic, public health crises may result in significant governmental measures being implemented to control the spread of a virus, including quarantines, travel restrictions, social distancing and business shutdowns.

filing / Aug 5, 2026 / receipt

The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our medicines and drug candidates.

filing / Aug 5, 2026 / receipt

Our risk profile is further heightened by remote work arrangements and our increasing reliance on third-party service providers to manage critical applications.

filing / Aug 5, 2026 / receipt

The continuing efforts of the government, insurance companies, managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls may adversely affect the demand for our product candidates, if we obtain regulatory approval; our ability to set a price that we believe is fair for our approved products; our ability to generate revenue and achieve or m

filing / Aug 5, 2026 / receipt

Additionally, as seen in connection with the COVID-19 pandemic, public health crises may result in significant governmental measures being implemented to control the spread of a virus, including quarantines, travel restrictions, social distancing and business shutdowns.

filing / May 6, 2026 / receipt

The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our medicines and drug candidates.

filing / May 6, 2026 / receipt

Our risk profile is further heightened by remote work arrangements and our increasing reliance on third-party service providers to manage critical applications.

filing / May 6, 2026 / receipt

The continuing efforts of the government, insurance companies, managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls may adversely affect the demand for our product candidates, if we obtain regulatory approval; our ability to set a price that we believe is fair for our approved products; our ability to generate revenue and achieve or m

filing / May 6, 2026 / receipt

Senior Clinical Research Associate | {"ats": "workday", "city": null, "state": null, "job_id": "/job/France-Remote/Senior-Clinical-Research-Associate_R36871", "remote": true, "category": "other", "fun

company_statement / Sep 16, 2026 / receipt

Key Account Manager Solid Tumors - Berlin, Brandenburg and Mecklenburg-Vorpommern | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Germany-Remote/Key-Account-Manager-Solid-Tumors---Be

company_statement / Sep 16, 2026 / receipt

Clinical Supply Chain Specialist | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Remote-US/Clinical-Supply-Chain-Specialist_R36432", "remote": true, "category": "other", "function":

company_statement / Sep 16, 2026 / receipt

Senior Director, Organizational Change Management, Global Technology Solutions | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Remote-US/Senior-Director--Organizational-Change-Manage

company_statement / Sep 16, 2026 / receipt